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Abstract: Background: Elevated L-type Ca2+ channel expression level increases Ca2+ infl ux. This can cause 
hypertrophy and pathological remodeling of the heart especially under stress conditions. Nesfatin-1 can acti-
vate hypothalamic L, P and Q type Ca2+ channels and increase insulin secretion in pancreatic islet beta cells 
via activation of L-type Ca2+ channels. On the other hand, the effect of nesfatin-1 on cardiac L-type Ca2+ chan-
nels has not been studied yet. 
Objectives: We aimed to identify the effect of peripheral chronic nesfatin-1 application on cardiac L-type Ca2+ 
channel α1c subunit expression level in normal rats and those subjected to chronic restraint stress.
Methods: Three-month aged Wistar albino rats were randomly divided into 4 groups (n = 7) as Control, Stress, 
Control+Nesfatin-1, and Nesfatin-1+Stress. Rats in groups subjected to restraint stress were placed in a spe-
cially built size-manipulable cabin for 2 h/day (between 10:00 and 12:00 a.m.) for 10 consecutive days without 
allowing water and food intake. Nesfatin-1 segment (0.25 nmol/g bw intraperitoneally) was applied during the 
10 consecutive days. Western blot analyses were performed to determine the expression level of L-type Ca2+ 
channel α1c subunit protein in rat cardiac extracts. 
Results: Cardiac L-type Ca2+ channel α1c subunit protein expression levels were increased signifi cantly after 
chronic peripheral nesfatin-1 application in rats subjected to restraint stress (p = 0.032). 
Conclusion: We can conclude that nesfatin-1 can cause cardiac failures during clinical treatments by elevating 
cardiac L-type Ca2+ channel α1c subunit protein expression level (Fig. 2, Ref. 26). Text in PDF www.elis.sk. 
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Introduction
Cardiac L-type Ca2+ channels determine physiological func-
tions of cardiac myocytes. These channels have an important 
role for many cell functions such as membrane excitability, Ca2+ 
homeostasis, protein phosphorylation and gene regulation (1). 
L-type Ca2+ channels initiate the pacemaker potential by Ca2+ in-
fl ux in cardiomyocytes and also cause the plateau phase of action 
potential. That is why they are also important for excitation-con-
traction coupling process in the heart (2, 3). L-type Ca2+ channels 
are pore-structured proteins and contain alfa-1c (α1c), alfa2/delta 
(α2/δ) and beta (β) subunits. The α1c subunit is the part sensitive 
to voltage and contains receptor regions for different classes of 
Ca2+ channel agonists and antagonists. Thus, α1c subunit is ac-
cepted as the main physiological regulator part of L-type Ca2+ 
channels (4). There should be a possible relationship between the 
level or function of L-type Ca2+ channels alterations and several 
heart diseases such as atrial fi brillation, and heart failure. Acute 
and chronic restraint stress applications can elevate the expression 
level of L-type Ca2+ channel (5, 6).
Nesfatin-1 is a peptide composed of 82 amino acids and de-
rived from the larger protein nucleobindin-2 (NUCB2). It regulates 
feeding and is distributed in the central nervous system (CNS) in-
cluding the hypothalamic paraventricular nucleus (PVN), arcuate 
nucleus (ARC), lateral hypothalamic area and supraoptic nucleus 
(SON) (7). Under stress conditions the level of nesfaitn-1 in the 
brain gets increased. This is accepted as a possible link between 
nesfatin-1 and stress (8). Intracerebroventricular (icv) and periph-
eral administrations of nesfatin-1 can increase blood pressure (9, 
10, 11). Recently, nesfatin-1 has been described as a cardiac peptide 
(12). It can activate hypothalamic L, P and Q type Ca2+ channels 
independently from blood pressure activation (13) and can also 
increase insulin secretion by activation of L- type Ca2+ channels in 
pancreatic islet beta cells (14). Consequently nesfatin-1 receives 
close attention, especially for its potential of becoming a novel 
therapeutic agent for diseases such as obesity and diabetes melli-
tus. If we consider that these diseases are chronic stress factors for 
human body, we believe that it is necessary to know more about 
nesfatin-1 effects under chronic stress conditions. Thus, we have 
applied chronic restraint stress to mimic stress condition created 
by diseases. On the other hand, the effect of nesfatin-1 on cardiac 
L- type Ca2+ channel has not been studied yet. Due to these rea-
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sons, in present study we aimed to determine the effect of periph-
eral chronic nesfatin-1 application on cardiac L-type Ca2+ channel 
α1c subunit expression level in normal rats and those subjected to 
chronic restraint stress. 
Material and method
Animals and experimental conditions
In this study, 28 three-month old Wistar Albino male rats were 
used, weighing 200–250 g. They were reared under the supervision 
of a veterinarian, kept in a well-ventilated, noiseless environment, 
and allowed free access to food and water. The rats were housed 
in a room with controlled temperature (23 ± 1 °C) and relative 
humidity (50 ± 5 %), and kept in transparent plastic cages (42 x 
26 x 15 cm), each containing three or four rats exposed to a 12:12 
light/dark cycle. All experimental protocols conducted on animals 
were consistent with the National Institutes of Health Guidelines 
for the Care and Use of Laboratory Animals (NIH Publication No. 
85–23) and approved by the Pamukkale University Ethics Com-
mittee of Animal Care and Usage.
Experimental design 
Rats were randomly divided into four experimental groups 
(n = 7) including; control (C) rats without any treatment, rats 
subjected to chronic restraint stress (S) without any injection, 
control+nesfatin-1 applied (C+N) rats, and nesfatin-1 applied + 
subjected to chronic restraint stress (N+S). Each time, nesfatin-1 
was applied just before chronic restraint stress application in N+S 
group. Rats were placed in a specially built size-manipulable cabin 
and to be able to create the animal model of restraint stress (15, 16) 
in stress groups, they were not allowed to water and food intake 
for 2 h/day (between 10:00–12:00 a.m.) for 10 consecutive days. 
Totally 14 rats in the C+N and N+S groups were treated with rat 
nesfatin-1 segment (0.25 nmol/g bw intraperitoneally) during 10 
consecutive days (17). 
Collection of heart samples 
At the end of the experimental period, all animals were anes-
thetized with ketamin/xylazine HCl (75 mg/kg/10 mg/kg intraperi-
toneally). Heart tissues of each rat were carefully cleaned from 
fat and connective tissues and placed in liquid nitrogen to freeze 
immediately. Heart samples were stored at - 80ºC until Western-
Blot analysis. 
Western blot analysis of L-type Ca2+ channel α1c subunit protein 
expression
To isolate proteins, heart tissues were homogenized in radio-
immunoprecipitation (RIPA) lysis buffer with a protease-inhibitor 
and centrifuged at 4 °C. Protein concentrations were measured 
by Lowry assay with bovine serum albumin (BSA) to load each 
sample in equal concentration to the gel. Proteins were denatured 
by loading buffer with sodium dodecyl sulfate (SDS), and run on 
10 % SDS-polyacrylamide gel using a mini-Protean cell (Bio-Rad, 
Hercules, CA, USA). Obtained bands were transferred to polyvi-
nylidine difl uoride (PVDF) membrane (Millipore, Bedford, MA, 
USA) using a Trans-Blot SD cell (Bio-Rad). For blocking step, the 
membrane was incubated with 1 % BSA in Tris at 4 °C overnight. 
For immunodetection, membranes were fi rst incubated with pri-
mary antibody (sc-25686, anti-cardiac α1c subunit, 1:500, Santa 
Cruz) for 2 hours at room temperature (RT) and after that they 
were incubated with secondary antibody (sc-2030, horseradish-
peroxidase-conjugated goat anti-rabbit IgG, 1:5000, Santa Cruz) 
for 1 h at RT. Immunoreactive bands were visualized by densitom-
etry by UVP BioSpectrum Imaging System (Upland, California, 
USA) using the chemiluminescence method. Density of each band 
was quantifi ed by the same system (Modifi ed protocol from 18). 
Statistical analysis
Statistical analyses were done by SPSS (Statistical Package 
for Social Sciences, Chicago, IL, USA) 16.0 package program. 
All data were given as mean ± standard deviation (SD). Statistical 
signifi cances among all groups and between two groups were ana-
lyzed by Kruskal–Wallis and Mann–Whitney U tests, respectively. 
Differences were considered signifi cant at P<0.05.
Results
Expression levels of heart L-type Ca2+ channel α1c subunit 
We observed no statistically signifi cant difference in expres-
sion levels of heart L-type Ca2+ channel α1c subunit among the 
C (15.06 ± 4.71), S (21.17 ± 7.63), C+N (19.23 ± 6.74) and N+S 
(25.73 ± 5.52) groups (p = 0.178). The level of heart L-type Ca2+ 
channel α1c subunit protein was signifi cantly increased in N+S 
compared to C group (p = 0.032) (Fig. 1). The increase in heart 
L-type Ca2+ channel α1c subunit protein expression level in N+S 
group compared to C group has been demonstrated also by West-
ern Blot analyses in which samples from rats selected randomly 
from each group were applied (Fig. 2). 
Discussion
Cardiac L-type Ca2+ channels play an important role for char-
acteristic physiological functions of cardiac myocytes (1). The 
Fig. 1. The expression levels of heart L-type Ca2+ channel α1c subunit 
in C, S, C+N and N+S groups. * The signifi cance between C and the 
other groups, p < 0.05 (Mann-Whitney U test).
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level or function of L-type Ca2+ channels is changing in sev-
eral heart diseases such as atrial fi brillation, and heart failure. 
That is why it is believed that there is a possible relationship 
between cardiovascular diseases and pathophysiological altera-
tions in Ca2+ homeostasis that is regulated by L-type Ca2+ chan-
nels. In addition, dysregulated Ca2+ homeostasis has a role in the 
pathogenesis of cell death (5). The α1c subunit is described as 
the main physiological regulatory part of L-type Ca2+ channels 
(4). Abnormal cardiovascular responses can occur after acute 
and chronic stress. Both types of stress can increase risk factors 
for the development of cardiovascular diseases (19). Chronic 
restraint stress is in relationship with cardiac dysfunction and 
structural changes. It can cause elevated expression level of L-
type Ca2+ channel α1c subunit as well as lead to cardiomyocyte 
damage (5, 6). Nesfatin-1 activates hypothalamic L, P and Q type 
Ca+2 channels and additionally L type Ca+2 channels in pancre-
atic beta cells which increase insulin secretion (13, 14). It is also 
very well known that nesfatin-1 inhibits feeding via a pathway 
that is different from that of leptin (20, 21). That is why it be-
came a very popular therapeutic target. It has been also shown 
that there could be a relationship between nesfatin-1 and stress 
conditions (8, 22, 23). Nevertheless there are still knowledge 
gaps in respect of direct cardiac effects of nesfatin-1. The effects 
of nesfatin-1 on feeding have been studied on a large scale. We 
believe that we still need to seek more information about physi-
ological effects of nesfatin-1 and mechanisms of these effects. 
That is why we hypothesized that nesfatin-1 could have adverse 
effects on cardimyocytes and using it in treatment procedures 
for various diseases such as obesity and diabetes mellitus could 
possibly lead to serious health problems. Thus, in present study, 
an experimental model was chosen to mimic human body under 
disease conditions.
In present study, we identifi ed the effect of peripheral chronic 
nesfatin-1 application on cardiac L-type Ca2+ channel α1c subunit 
expression level in normal and chronic restraint stress created rats. 
Chronic restraint stress during 21 days of application increases the 
expression level of α1c subunit of heart L-type Ca2+ channels (5). In 
this study, the applied stress model is described as a chronic stress 
model (16). Although not signifi cantly, we observed elevated levels 
of heart L-type Ca2+ channels α1c subunit in S group compared to 
C group. We assume that different characteristics and durations of 
stress application can change the expression level of heart L-type 
Ca2+ channels α1c subunit in mutually different manners. That is 
why we can conclude that the applied stress model in the present 
study may elevate the expression level of heart L-type Ca2+ chan-
nels α1c subunit. In literature, we failed to observe any report about 
the effect of peripheral nesfatin-1 application on heart L-type Ca2+ 
channels α1c subunit. Compared to C group, we found the level of 
heart L-type Ca2+ channels α1c subunit in C+N group to be elevat-
ed, although not signifi cantly. In addition, a statistically signifi cant 
increase was found in the level of heart L-type Ca2+ channels α1c 
subunit in N+S group compared to C group. Unfortunately, accord-
ing to our results it is not possible to claim that this elevation was 
directly caused by stress conditions or nesfatin-1 administration. 
Although they both elevate the level of heart L-type Ca2+ chan-
nels α1c subunit, this effect is not signifi cant. If we consider that 
this elevation is statistically signifi cant in N+S, we can conclude 
that chronic peripheral nesfatin-1 administration can increase the 
expression level of heart L-type Ca2+ channels α1c subunit protein 
especially under chronic stress conditions.
Conclusion
Cardiovascular effects of nesfatin-1 should be in tight relation 
with direct cardiac effect of nesfatin-1. If nesfatin-1 is thought to 
be used as an effective therapeutic agent, we believe it is necessary 
to know more about its effects on different tissues under different 
conditions. According to the present study, we can conclude that 
nesfatin-1 application can have adverse effect on cardimyocytes 
and can lead to serious health problems during clinical treatment 
by elevating the expression level of heart L-type Ca2+ channels 
α1c subunit protein.
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